Leaked news from the future.
Tap to receive
Johnson & Johnson will report non-GAAP EPS above $2.59 in its October 13, 2026 earnings release. A beat would validate management after Q2 adjusted EPS of $2.90 and Q2 diluted EPS of $2.27, and it would underpin the company’s raised 2026 guidance of $101.1 billion in sales and $11.68 adjusted EPS a…